Metformin Hydrochloride Rosemont Pharmaceuticals

Active Ingredient:: Metformin Hydrochloride
Origin:: EU

Metformin Hydrochloride Rosemont Pharmaceuticals (Metformin Hydrochloride)

Q: What is Metformin Hydrochloride Rosemont Pharmaceuticals used for?

Metformin Hydrochloride Rosemont Pharmaceuticals is an oral biguanide indicated to improve blood glucose control in adults with type 2 diabetes mellitus. It works by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, helping patients achieve target glycaemic levels as part of a comprehensive diabetes management plan.

Q: How does Metformin Hydrochloride work?

Metformin Hydrochloride inhibits mitochondrial respiratory‑chain complex I, which reduces the liver’s production of glucose. It also lowers intestinal glucose absorption and increases glucose uptake by muscle cells, thereby improving overall insulin sensitivity without directly stimulating insulin release.

Q: What is the usual dose of Metformin Hydrochloride?

The prescribed dose of Metformin Hydrochloride is individualized by the treating clinician based on the patient’s renal function, glycaemic targets, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule, and patients should follow the specific instructions provided by their healthcare professional.

Q: Is Metformin Hydrochloride safe during pregnancy or breastfeeding?

Metformin Hydrochloride is classified as pregnancy category B, indicating that animal studies have not shown risk and there are no well‑controlled human studies. It may be used during pregnancy when the potential benefit justifies the potential risk. Limited data suggest it is excreted in breast milk, so clinicians weigh benefits against possible infant exposure.

Q: How do I order Metformin Hydrochloride Rosemont Pharmaceuticals from GNH India?

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Q: How does Metformin compare with other antidiabetic classes?

Metformin belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, and SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycaemia when used alone and has a favourable impact on weight. It is often first‑line therapy because of its efficacy, safety profile, and low cost compared with newer agents.

Q: What are the storage and handling requirements for Metformin Hydrochloride?

Metformin Hydrochloride tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture, direct sunlight, and excessive heat to maintain potency throughout its shelf life.

Q: How is Metformin Hydrochloride administered?

Metformin Hydrochloride is taken orally, usually with meals to reduce gastrointestinal upset. The tablets are swallowed whole with a full glass of water. Patients should not crush, chew, or split extended‑release formulations unless specifically instructed by a healthcare professional.

Q: What are the most serious risks associated with Metformin Hydrochloride?

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or during exposure to iodinated contrast media. Prompt discontinuation and medical evaluation are essential if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Q: Who should not use Metformin Hydrochloride?

Metformin Hydrochloride is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic liver disease, a history of lactic acidosis, or those undergoing radiographic procedures using iodinated contrast agents without appropriate discontinuation. It should also be avoided in individuals with known hypersensitivity to metformin or any of its excipients.

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Rosemont Pharmaceuticals, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus.
GNH India supplies Metformin Hydrochloride Rosemont Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Rosemont Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Metformin Hydrochloride is an oral antidiabetic that lowers elevated blood glucose in the type 2 diabetes pathway.
Type 2 diabetes mellitus: improves glycaemic control by reducing hepatic glucose output and enhancing peripheral insulin sensitivity.

How It Works

Metformin Hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. It also decreases intestinal glucose absorption and increases peripheral glucose uptake in muscle, thereby improving overall insulin sensitivity without directly stimulating insulin secretion.

Side Effects

Metformin Hydrochloride may cause a range of adverse reactions.

Common Side Effects

Nausea: mild to moderate stomach upset.
Diarrhoea: frequent loose stools, especially at treatment initiation.
Abdominal discomfort: cramping or bloating.
Metallic taste: transient alteration of taste perception.
Loss of appetite: reduced desire to eat.
Vitamin B12 deficiency: gradual decrease with long‑term use.

Serious or Rare Side Effects

Lactic acidosis: rare but potentially fatal metabolic acidosis.
Severe skin reactions: such as Stevens‑Johnson syndrome.
Hepatic dysfunction: elevated liver enzymes or hepatitis.
Hypoglycaemia: uncommon unless combined with other glucose‑lowering agents.
Persistent gastrointestinal bleeding: very rare.
Anaphylactic reaction: immediate hypersensitivity.

Precautions & Warnings

Metformin Hydrochloride requires careful monitoring in several clinical situations.

Renal function assessment: avoid use in severe renal impairment (eGFR <30 mL/min/1.73 m²).
Hepatic disease evaluation: contraindicated in acute or chronic liver failure.
Lactic acidosis risk: discontinue before radiographic contrast studies.
Pregnancy safety: category B; use only if benefits outweigh potential risks.
Vitamin B12 monitoring: check levels periodically during long‑term therapy.
Store at ambient temperature: keep in original container, protect from moisture and heat.

Avoid Interactions

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

Iodinated contrast agents: may precipitate lactic acidosis; withhold metformin before and after use.
Cimetidine: increases metformin plasma concentrations.
Other biguanides: additive risk of lactic acidosis.
Alcohol excess: enhances risk of lactic acidosis.
Rifampicin: reduces metformin exposure.

Moderate Interactions (Monitor Closely)

Beta‑blockers: may mask hypoglycaemic symptoms.
Diuretics (loop or thiazide): can affect renal clearance.
ACE inhibitors/ARBs: monitor renal function and electrolytes.
NSAIDs: may impair renal function, increasing metformin levels.
Warfarin: occasional alteration of INR; monitor coagulation.

Frequently Asked Questions

Metformin Hydrochloride Rosemont Pharmaceuticals is an oral biguanide indicated to improve blood glucose control in adults with type 2 diabetes mellitus. It works by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, helping patients achieve target glycaemic levels as part of a comprehensive diabetes management plan.

Metformin Hydrochloride inhibits mitochondrial respiratory‑chain complex I, which reduces the liver’s production of glucose. It also lowers intestinal glucose absorption and increases glucose uptake by muscle cells, thereby improving overall insulin sensitivity without directly stimulating insulin release.

The prescribed dose of Metformin Hydrochloride is individualized by the treating clinician based on the patient’s renal function, glycaemic targets, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule, and patients should follow the specific instructions provided by their healthcare professional.

Metformin Hydrochloride is classified as pregnancy category B, indicating that animal studies have not shown risk and there are no well‑controlled human studies. It may be used during pregnancy when the potential benefit justifies the potential risk. Limited data suggest it is excreted in breast milk, so clinicians weigh benefits against possible infant exposure.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metformin belongs to the biguanide class, which differs from sulfonylureas, DPP‑4 inhibitors, and SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not cause hypoglycaemia when used alone and has a favourable impact on weight. It is often first‑line therapy because of its efficacy, safety profile, and low cost compared with newer agents.

Metformin Hydrochloride tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture, direct sunlight, and excessive heat to maintain potency throughout its shelf life.

Metformin Hydrochloride is taken orally, usually with meals to reduce gastrointestinal upset. The tablets are swallowed whole with a full glass of water. Patients should not crush, chew, or split extended‑release formulations unless specifically instructed by a healthcare professional.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal or hepatic impairment, excessive alcohol intake, or during exposure to iodinated contrast media. Prompt discontinuation and medical evaluation are essential if symptoms such as unexplained fatigue, rapid breathing, or abdominal pain develop.

Metformin Hydrochloride is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic liver disease, a history of lactic acidosis, or those undergoing radiographic procedures using iodinated contrast agents without appropriate discontinuation. It should also be avoided in individuals with known hypersensitivity to metformin or any of its excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 05 Sep 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.